ChemicalBook >> CAS DataBase List >>PROTAC SMARCA2 degrader-2
PROTAC SMARCA2 degrader-2
- CAS No.
- 2892523-74-7
- Chemical Name:
- PROTAC SMARCA2 degrader-2
- Synonyms
- PROTAC SMARCA2 degrader-2;2-Pyrrolidinecarboxamide, 1-[(2R)-2-[3-[2-[4-[[7′,8′-dihydro-3′-(2-hydroxyphenyl)spiro[piperidine-4,6′(5′H)-pyrazino[2,3-c]pyridazin]-1-yl]methyl]-1-piperidinyl]ethoxy]-5-isoxazolyl]-3-methyl-1-oxobutyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-, (2S,4R)-;(2S,4R)-4-hydroxy-1-[(2R)-2-{3-[2-(4-{[3'-(2-hydroxyphenyl)-7',8'-dihydro-5'H-spiro[piperidine-4,6'-pyridazino[3,4-b]pyrazin]-1-yl]methyl}piperidin-1-yl)ethoxy]-1,2-oxazol-5-yl}-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide
- CBNumber:
- CB014209840
- Molecular Formula:
- C49H62N10O6S
- Molecular Weight:
- 919.15
- MDL Number:
- MOL File:
- 2892523-74-7.mol
Last updated:2025-05-19 13:47:24
PROTAC SMARCA2 degrader-2 Chemical Properties, Uses, Production
Uses
PROTAC SMARCA2 degrader-2 is a potent and selective SMARCA2/4 PROTAC degrader with an IC50 of <0.1 μΜ in HeLa HiBiT assay. PROTAC SMARCA2 degrader-2 is extracted from patent WO2023287787A1 and has the potential for SMARCA4-related or deficient cancer research[1].
References
[1] Liang Lu, et al. Brm targeting compounds and associated methods of use. Patent WO2023287787A1.
PROTAC SMARCA2 degrader-2 Preparation Products And Raw materials
Raw materials
Preparation Products
PROTAC SMARCA2 degrader-2 Suppliers
Global Suppliers ( 2)
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Jilin Province Woda Biotechnology Co., Ltd. | 13504435624 | 1927928688@qq.com | China | 1644 | 58 |
| Nantong QuanYi Biotechnology Co., Ltd | 0513-66337626 18051384581 | sales@chemhifuture.com | China | 5985 | 58 |
| Supplier | Advantage |
|---|---|
| Jilin Province Woda Biotechnology Co., Ltd. | 58 |
| Nantong QuanYi Biotechnology Co., Ltd | 58 |
2892523-74-7 (PROTAC SMARCA2 degrader-2) Related Search:
PROTAC SMARCA2 degrader-2
(2S,4R)-4-hydroxy-1-[(2R)-2-{3-[2-(4-{[3'-(2-hydroxyphenyl)-7',8'-dihydro-5'H-spiro[piperidine-4,6'-pyridazino[3,4-b]pyrazin]-1-yl]methyl}piperidin-1-yl)ethoxy]-1,2-oxazol-5-yl}-3-methylbutanoyl]-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide
2-Pyrrolidinecarboxamide, 1-[(2R)-2-[3-[2-[4-[[7′,8′-dihydro-3′-(2-hydroxyphenyl)spiro[piperidine-4,6′(5′H)-pyrazino[2,3-c]pyridazin]-1-yl]methyl]-1-piperidinyl]ethoxy]-5-isoxazolyl]-3-methyl-1-oxobutyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-, (2S,4R)-
2892523-74-7




